The treatment model of triple-negative breast cancer, a more invasive subtype of breast cancer, requires a combination of factors. First, surgical treatment is the primary means of treating triple-negative breast cancer. After diagnosis, doctors usually recommend mammography, depending on the size of the tumor, its location and the age and overall health of the patient, sometimes including lymphomy. The aim of the operation is to remove the tumor tissue as much as possible and to reduce the risk of relapse.
chemotherapy plays a crucial role in the treatment of triple-negative breast cancer. Due to the lack of estrogen receptor, congener hormone receptor and HeR2 protein, this type of breast cancer is insensitive to endocrine treatment and to the treatment of HeR2. As a result, chemotherapy has become the main complementary treatment. Patients may receive chemotherapy programmes that include onion-like drugs, such as Dosubi and Sphinx, as well as violet-type drugs, such as Visumiol and Dositas. These drugs can be effective in killing cancer cells, but can also have significant side effects, such as disempowerment, nausea, vomiting and bone marrow suppression.
Treatment is also an important treatment option for patients who are at risk of re-emerging breast cancer at a later stage. It destroys the DNA of cancer cells through high-energy radiation, thus inhibiting their growth and spread. Treatment is usually performed after the operation to reduce the likelihood of local relapse.
As for target-oriented treatment, specific target-oriented drugs for triple-negative breast cancer are currently in the development stage. However, as medical research progresses, there may be more targeted treatments for this type of breast cancer in the future. In addition, professional medical teams are able not only to provide professional medical advice and treatment programmes, but also to provide timely guidance and assistance in case of any discomfort or anomaly. The patient should therefore regularly report to the doctor on his/her condition, including any new symptoms or persistent problems.
Patients may face emotional challenges in treatment and rehabilitation, such as anxiety, fear and frustration. These emotional responses are normal, but they also require appropriate attention and treatment. In addition to sharing feelings with relatives and friends, patients may consider seeking professional counselling or participating in cancer support groups. Communication with people with similar experiences allows patients to feel no longer alone and to draw inspiration and encouragement from their experience. In addition, new treatments and drugs are emerging as medical technologies continue to improve. Patients and their families should follow the latest developments in scientific research and learn about new treatments that may be appropriate for themselves. Of course, before any new treatment can be tried, it is important that it be fully discussed and evaluated with doctors to ensure safety and effectiveness. In dealing with triple-negative breast cancer, patients also need to learn how to manage their daily lives and work. As treatment and rehabilitation may require considerable time and effort, patients may need to adjust their work plans and day-to-day activities. This includes reducing work stress, avoiding overwork and ensuring adequate rest and sleep time.
Finally, patients should develop positive life attitudes and optimism. Despite the fact that triple-negative breast cancer is a serious disease, many patients are able to recover their health and enjoy a better life through active treatment and rehabilitation measures. The patient should therefore remain confident that he or she can overcome the disease and hope for a better future.
